BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 6512792)

  • 1. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-penicillamine in rheumatoid arthritis : hematological incidents and accidents (author's transl)].
    Franck JL; Bouteiller G; Gayrard M; Arlet J
    Sem Hop; 1979 Sep 8-15; 55(27-30):1325-7. PubMed ID: 228408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancytopenia related eosinophilia in rheumatoid arthritis.
    Jaffe IA
    J Rheumatol; 1996 Feb; 23(2):406. PubMed ID: 8882061
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evans' syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination].
    Masson C; Brégeon C; Ifrah N; Berton V; Housseau F; Rénier JC
    Rev Rhum Mal Osteoartic; 1991; 58(7):519-22. PubMed ID: 1925397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of D-penicillamine therapy in Japan.
    Kashiwazaki S
    Z Rheumatol; 1988; 47 Suppl 1():38-40. PubMed ID: 3213270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Penicillamine: its use in rheumatoid arthritis].
    Colombo B; Gerloni V
    Recenti Prog Med; 1979 Feb; 66(2):136-87. PubMed ID: 155862
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic toxicity from penicillamine in rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():164-5. PubMed ID: 6939880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis.
    Dominkus M; Grisold W; Albrecht G
    Muscle Nerve; 1992 Nov; 15(11):1300-1. PubMed ID: 1488070
    [No Abstract]   [Full Text] [Related]  

  • 18. Eosinophilia in D-penicillamine therapy.
    Smith DH; Scott DL; Zaphiropoulos GC
    Ann Rheum Dis; 1983 Aug; 42(4):408-10. PubMed ID: 6136256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The failures of D penicillamine].
    Ayrolles C; Guyard C; Fournié A
    Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):161-4. PubMed ID: 653292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillamine in rheumatoid arthritis - a 2 year retrospective study in 70 patients.
    Dippy JE
    Br J Clin Pract; 1977; 31(1-3):5-11. PubMed ID: 857823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.